Balentine LLC’s Novartis NVS Stock Holding History

Balentine LLC’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-28,257	Closed	-$2.73M	–	438
2024 Q1	$2.73M	Buy	28,257 +518	+2%	+$50.1K	0.08%	81
2023 Q4	$2.8M	Buy	27,739 +2,699	+11%	+$273K	0.09%	79
2023 Q3	$2.55M	Buy	25,040 +5,814	+30%	+$592K	0.09%	72
2023 Q2	$1.94M	Buy	19,226 +68	+0.4%	+$6.86K	0.06%	92
2023 Q1	$1.76M	Buy	19,158 +2,151	+13%	+$198K	0.06%	103
2022 Q4	$1.54M	Buy	17,007 +2,337	+16%	+$212K	0.05%	128
2022 Q3	$1.12M	Sell	14,670 -5,092	-26%	-$387K	0.04%	142
2022 Q2	$1.67M	Buy	19,762 +9,090	+85%	+$768K	0.06%	135
2022 Q1	$936K	Buy	10,672 +3,538	+50%	+$310K	0.03%	182
2021 Q4	$624K	Buy	7,134 +1,659	+30%	+$145K	0.02%	141
2021 Q3	$448K	Buy	5,475 +336	+7%	+$27.5K	0.02%	130
2021 Q2	$469K	Buy	5,139 +414	+9%	+$37.8K	0.02%	88
2021 Q1	$404K	Buy	4,725 +432	+10%	+$36.9K	0.02%	87
2020 Q4	$405K	Buy	4,293 +685	+19%	+$64.6K	0.02%	79
2020 Q3	$314K	Buy	3,608 +1,205	+50%	+$105K	0.02%	91
2020 Q2	$210K	Buy	+2,403	New	+$210K	0.01%	96
2019 Q4	–	Sell	-993	Closed	-$86K	–	701
2019 Q3	$86K	Hold	993	–	–	0.01%	106
2019 Q2	$91K	Buy	993 +58	+6%	+$5.32K	0.01%	72
2019 Q1	$81K	Hold	935	–	–	0.01%	99
2018 Q4	$72K	Buy	935 +600	+179%	+$46.2K	0.01%	99
2018 Q3	$26K	Buy	+335	New	+$26K	﹤0.01%	116
2018 Q1	–	Sell	-305	Closed	-$23K	–	379
2017 Q4	$23K	Hold	305	–	–	﹤0.01%	366
2017 Q3	$23K	Sell	305 -20	-6%	-$1.51K	﹤0.01%	372
2017 Q2	$24K	Buy	325 +16	+5%	+$1.18K	﹤0.01%	349
2017 Q1	$21K	Sell	309 -18	-6%	-$1.22K	﹤0.01%	342
2016 Q4	$21K	Buy	327 +84	+35%	+$5.39K	﹤0.01%	320
2016 Q3	$17K	Buy	243 +68	+39%	+$4.76K	﹤0.01%	296
2016 Q2	$13K	Hold	175	–	–	﹤0.01%	307
2016 Q1	$11K	Sell	175 -71	-29%	-$4.46K	﹤0.01%	245
2015 Q4	$19K	Sell	246 -158	-39%	-$12.2K	﹤0.01%	257
2015 Q3	$33K	Buy	404 +119	+42%	+$9.72K	0.01%	225
2015 Q2	$25K	Buy	285 +13	+5%	+$1.14K	﹤0.01%	243
2015 Q1	$24K	Buy	+272	New	+$24K	﹤0.01%	226